Lactobacillus Gasseri CP2305 Postbiotic

As an innovative leader in the microbiome field, ADM delivers future-forward nutrition powered by science, offering a full range of clinically documented solutions—from prebiotics to probiotic and postbiotic strains—supporting health and wellness. Lactobacillus gasseri CP2305 is an advanced postbiotic strain recognized for benefits in emotional well-being, healthy sleep quality, and more. It acts on the gut-brain axis, modulating the gut microbiome and helping maintain beneficial Bifidobacteria under stress (Nishida K et al., Nutrients 2019;11:1859). Backed by 8+ human clinical trials, CP2305 shows results in sleep, stress, mood, women’s health, and exercise recovery. Research suggests supplementation may support emotional balance, stress reduction, and improved sleep—enhancing efficiency, latency, duration, and self-reported well-being. Clinical evidence also indicates that daily intake of 10B cells of L. gasseri CP2305 may aid recovery after exercise and promote emotional and physical improvements in women experiencing premenstrual or menopausal symptoms, including positive changes in physiological and emotional parameters. Postbiotics mark a new era in gut-brain axis innovation. Defined as “a preparation of inanimate microorganisms and/or their components that confer a health benefit on the host” (ISAPP), postbiotics deliver unique advantages through exceptional stability, maintaining efficacy across diverse formulations. Lactobacillus gasseri CP2305 represents a next-generation postbiotic with vast formulation potential. Nishida et al., 2017 J. Appl. Microbiol. 123:1561–1570; Nishida et al., 2017 J. Funct. Foods 36:112–121; Nishida et al., 2019 Nutrients 11:1859; Nishida et al., 2021 J. Funct. Foods 80:104426; Sawada et al., 2019 J. Funct. Foods 57:465–476; Sawada et al., 2022 Nutrients 14:1695. For B2B use only. Claims are not regulatory-approved. Verify local regulations for ingredient and claim permissibility.